Pay in 4 interest-free payments of $5.81 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Molecular & Chemical Characteristics Type: Synthetic dualagonist peptide (GIPR + GLP1R) Form: Lyophilized peptide powder Size: 10 mg vial Identity Verification: Mass Spectrometry (MS) Purity Analysis: HPLC / UPLC Structural Features Sequencelevel substitutions designed to improve enzymatic stability Fattyacid side chain enabling albumin interaction in vitro Demonstrates dualreceptor engagement with measurable receptor bias Biochemical Behavior Solubility dependent on pH, buffer system, and ionic strength Lipidated peptides may aggregate if improperly prepared Sensitive to oxidation and hydrolysis postreconstitution Storage & Handling Guidelines Store lyophilized peptide at 20 C , protected from light and moisture Reconstituted solutions: 28 C, shortterm research use only Avoid repeated freezethaw cycles Aliquot after reconstitution if required Use lowbinding laboratory consumables to reduce peptide adsorption Certificate of Analysis (COA) & Documentation Each batch of Tirzepatide supplied by BlueNexLabs includes auditready documentation , consisting of: MS identity confirmation HPLC / UPLC purity results Solvent system disclosure Lot & batch traceability View Certificate of Analysis (COA) Learn About Our Testing Standards Explore the BlueNexLabs Research Peptide Catalog Supplied for Canadian Research Laboratories BlueNexLabs provides Tirzepatide research peptide to laboratories across Canada , including: Vancouver Toronto Montreal Calgary Edmonton Ottawa Nationwide Why Researchers Choose BlueNexLabs ResearchUseOnly (RUO) labeling Fast fulfillment & knowledgeable support Peptide catalog built for regulated research environments Compliance Notice This product is supplied strictly for laboratory research use only (RUO)
As they near a new balance, maybe 40% of the weight might still be kept off after a year
The gap between demonstrating a mechanism in cell culture and demonstrating meaningful health outcomes from an oral supplement is enormous
More patients receiving semaglutide discontinued treatment due to GI adverse reactions than patients receiving placebo during all clinical trials
While losing weight gradually can help minimize muscle loss, the rate of weight loss on GLP-1 medications varies by individual
Read about NCLs impact Script Your Future saved my life Cincinnati resident Charles, 45, lost his computer business and health insurance during a time of economic downturn
